Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 56 min ago
Peer-reviewedLicence not statedPharmacology & therapeutics

Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future

  • Niti Kumari1
  • Surendra K Shukla2
  • Ravi Thakur3
  1. 1Biomedical Sciences Department, Creighton University, Omaha, NE, USA
  2. 2Oncology Science Department, College of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK, USA
  3. 3Department of Life Sciences, Christ University, Bengaluru, India
Read full textDOICite

Related

  1. Breast Cancer Surgery: Past, Present and Future—A Narrative Review
    Paolo Izzo, Marcello Molle, Pierfrancesco Di Cello +6
    Journal of Clinical MedicinePeer-reviewedCC BY6 citedOncologyOpenAlex
  2. Targeting the USP13–ACLY axis in tumor endothelial cells: Ginsenoside Rd suppresses pathological angiogenesis through metabolic-epigenetic reprogramming
    Haobin Li, Haocheng Deng, Jiali Liu +13
    Acta pharmaceutica Sinica. BPeer-reviewedCC BY-NC-NDFull textPharmacology & toxicologyEurope PMCPMC
  3. HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
    M. Rathore, C. Wei, J. Winter +1
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  4. 944 Succinate-based metabolic reprogramming of innate and adaptive immunity for ovarian cancer immunotherapy
    Remya Raja, Christopher Wu, Marion Curtis +6
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  5. Combined siRNA Targeting IκBα and Stat6 Promotes Macrophage Reprogramming toward Cancer Immunotherapy
    Sezen Gul, Juliette Vergnaud, Qinglin Wang +10
    Molecular PharmaceuticsPeer-reviewedCC BY 4.0Full textProteomics & metabolomicsImmunologyHAL

Cite

BibTeXRIS
BibTeX
@article{kumari2026targeting,
  title = {{Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future}},
  author = {Niti Kumari and Surendra K Shukla and Ravi Thakur},
  journal = {Pharmacology \& therapeutics},
  year = {2026},
  month = aug,
  doi = {10.1016/j.pharmthera.2026.109109},
  url = {https://doi.org/10.1016/j.pharmthera.2026.109109},
}
RIS
TY  - JOUR
TI  - Targeting Metabolic Reprogramming in Cancer: Past, Present, and Future
AU  - Niti Kumari
AU  - Surendra K Shukla
AU  - Ravi Thakur
PY  - 2026
DA  - 2026/08/29
JO  - Pharmacology & therapeutics
DO  - 10.1016/j.pharmthera.2026.109109
UR  - https://doi.org/10.1016/j.pharmthera.2026.109109
SN  - 0163-7258
SN  - 1879-016X
ER  -